Secukinumab showed superiority over Enbrel®
Novartis announced results from the head-to-head Phase III FIXTURE study showing secukinumab an interleukin-17A inhibitor,...
2013 Utah Life Science Summit Features Top State and National Leaders, Unrivalled Networking Opportunities
BioUtah today released the agenda for the 2013 Utah Life Science Summit Utah’s premier life...
Lannett Announces Proposed Public Offering of Common Stock
Lannett Company Inc. today announced that it and certain selling stockholders intend to offer shares...
Cancer Vaccine Company DCPrime and Janssen To Collaborate on Potential New Therapy
Cancer vaccine company DCPrime BV today announced that it has entered into a research and...
Marshall, Gerstein & Borun Named Patent Strategy and Management Team of the Year by...
Marshall Gerstein & Borun LLP an intellectual property law firm was recognized as Patent Strategy...
Abstral ,Manufactured and packaged by Recipharm AB for Kyowa Hakko Kirin, has been approved...
Approval to manufacture highly potent compound for breakthrough pain relief in cancer treatment granted. ...
Global regulatory affairs specialist ELC Group appoints former MHRA Expert Medical Assessor
ELC GROUP, one of the fastest-growing providers of regulatory affairs consulting services, today announced that...
First Country in Europe launches LATUDA® – a New Atypical Antipsychotic for Adults...
LATUDA® (lurasidone), a new once-daily treatment for schizophrenia, is now available in Switzerland for the...
Veristat to Assist on Adaptive Enrichment Trial for Verastem’s Defactinib in Mesothelioma
Veristat LLC. a leading Boston-based clinical research organization today announced its advisory role on the...
Oncodesign and Banook Central Imaging sign a collaboration agreement to develop biomarkers in clinical...
Oncodesign, a contract research laboratory dedicated to the discovery of new anticancer therapies, and Banook...
